Premium
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry
Author(s) -
Inzinger M.,
Heschl B.,
Weger W.,
Hofer A.,
Legat F.J.,
GruberWackernagel A.,
Tilz H.,
Salmhofer W.,
Quehenberger F.,
Wolf P.
Publication year - 2011
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2011.10396.x
Subject(s) - medicine , psoriasis , etanercept , ustekinumab , adalimumab , psoriasis area and severity index , efalizumab , dermatology , puva therapy , infliximab , plaque psoriasis , tumor necrosis factor alpha
Few studies have directly compared the clinical efficacy of psoralen plus ultraviolet A (PUVA) vs. biologics in the treatment of psoriasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom